The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,716,011 in first-year total cost, median $691,843.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-2 (M1)]8
Most frequent institutions
- EMORY UNIVERSITY1
- GEORGETOWN UNIVERSITY1
- H. LEE MOFFITT CANCER CTR & RES INST1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- OHIO STATE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Survivorship in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-cell Therapy1R01CA281756-01A1 | HANSEN, DORIS KOSWALD, LAURA B.PERES, LAUREN COLE | H. LEE MOFFITT CANCER CTR & RES INST, FL | $691,118 | ZCA1 |
| 2024 | Biological and social determinants of psychosocial sequelae in advanced head and neck cancer survivors receiving immunotherapy1R01CA281873-01A1 | FEDIRKO, VERONIKAXIAO, CANHUA | EMORY UNIVERSITY, GA | $664,304 | ZCA1 |
| 2024 | Randomized clinical trial of a telemedicine-mHealth symptom cluster intervention for advanced cancer patients: Increasing access in underserved rural communities1R01CA281885-01A1 | WELLS-DI GREGORIO, SHARLA MAELYN | OHIO STATE UNIVERSITY, OH | $656,014 | ZCA1 |
| 2024 | Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living with Likely Incurable Cancer1R01CA281740-01A1 | DAHNE, JENNIFER RENEEGRABOYES, EVAN MICHAEL | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $621,732 | ZCA1 |
| 2023 | A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors1R01CA281862-01 | KAMEN, CHARLES STEWARTSAKODA, LORIYAO, SONG | ROSWELL PARK CANCER INSTITUTE CORP, NY | $815,928 | ZCA1 |
| 2023 | Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)1R01CA281861-01 | CRANE, TRACY EDIELI-CONWRIGHT, CHRISTINALIGIBEL, JENNIFER A. | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $810,559 | ZCA1 |
| 2023 | Population-based assessment of patient-reported outcomes in adults living with metastatic colorectal cancer1R01CA281752-01 | POTOSKY, ARNOLD L | GEORGETOWN UNIVERSITY, DC | $763,788 | ZCA1 |
| 2023 | Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial1R01CA281759-01 | AGARWAL, NEERAJCOLETTA, ADRIANA | UNIVERSITY OF UTAH, UT | $692,568 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.